KREF Earnings

KREF reported its earnings on 2026-02-03, showcasing a revenue of 0.00 against an estimate of 26.00M, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0.1 by 0% . The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following KREF's earnings announcement on 2026-02-03, the stock price moved by % on the day of the release. Over the subsequent five days, it saw a % change. Historically, KREF's stock price tends to shift by an average of +1.08% in the 10 days leading up to earnings and +0.40% in the 10 days following, providing insight into potential market.

For 2025/Q2, analysts estimate KREF’s annual revenue to reach 33.00M, while the EPS is projected at 0.00. These estimates reflect recent revisions, with revenue estimates revised Revenue No Change by 0% and EPS estimates No Change by 0% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between KREF's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were No Change by 0%, while EPS estimates moved No Change by 0% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, KREF's stock price typically moves by +1.08% in the 10 days before its earnings and +0.40% in the 10 days after. For the upcoming 2025/Q2 earnings, analysts expect an EPS of 0.00 and revenue of 33.00M.

The earnings call indicates a mixed outlook. Financial performance is stable but not strong, with GAAP net income unchanged and distributable earnings negative. Share repurchases and liquidity are positives, but book value and leverage metrics show slight declines. Management's optimism on life sciences and strategic diversification is tempered by unresolved REO assets and unclear guidance on European originations. The Q&A revealed some concerns about asset performance and market strategy, but no critical risks. Overall, the sentiment is balanced, leading to a neutral stock price prediction.